Lifemd, Inc. SEC Filings

LFMDP NASDAQ

Welcome to our dedicated page for Lifemd SEC filings (Ticker: LFMDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

LifeMD’s business model blends recurring telehealth subscriptions with custom diagnostic devices, leaving investors to mine hundreds of pages for revenue recognition rules, HIPAA compliance costs, and preferred-stock dividend details. Finding that data across a 300-page 10-K or a fast-moving 8-K can be time-intensive.

Stock Titan’s AI answers the problem. Our platform ingests every LifeMD SEC filing the moment it hits EDGAR and delivers plain-English summaries within minutes. Whether you search for “LifeMD insider trading Form 4 transactions” or “LifeMD quarterly earnings report 10-Q filing,” you’ll see the exact line items—subscription churn, patient-acquisition spend, or telehealth equipment margins—highlighted and explained.

All core documents are covered in real time:

Annual report 10-K—subscription economics, HIPAA compliance expenses—fully annotated for those asking “LifeMD annual report 10-K simplified”.
Quarterly 10-Q—visit growth and cost trends; ideal for “LifeMD earnings report filing analysis”.
8-K material events—FDA guidance or new insurer contracts, surfaced under “LifeMD 8-K material events explained”.
Form 4—executive stock moves pushed via “LifeMD executive stock transactions Form 4” alerts with real-time context.
Proxy statement—board and “LifeMD proxy statement executive compensation” details distilled into digestible metrics.

Need to understand dilution triggers in the preferred shares trading as LFMDP? Want “LifeMD SEC filings explained simply” before the market opens? Our expert analysis and AI-powered summaries turn dense disclosures into actionable insights so you can compare quarter-over-quarter trends, monitor insider sentiment, and make informed decisions—without wading through legalese.

06/18/2025 06:18 PM

Filing

[Form 4] LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock Insider Trading Activity

Rhea-AI Summary

LifeMD, Inc. – Form 4 insider activity

Chief Financial Officer Marc David Benathen disclosed two open-market sales of LifeMD (ticker LFMD) common stock. On 06/16/2025 he sold 75,000 shares at a weighted-average price of $13.0926 (individual trades between $12.57-$13.57). On 06/17/2025 he sold an additional 50,000 shares at a weighted-average price of $14.0099 (trades between $14.00-$14.07). Total shares disposed: 125,000.

After the transactions, Benathen’s direct ownership decreased from 464,554 to 339,554 shares, a reduction of roughly 26.9 % of his previously reported direct stake. No purchases or derivative security transactions were reported in Table II. The filing, signed on 06/18/2025, does not indicate the use of a Rule 10b5-1(c) trading plan.

This Form 4 provides investors with updated information on insider ownership and trading activity by a key executive officer.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Lifemd (LFMDP)?

The current stock price of Lifemd (LFMDP) is $24.2045 as of June 27, 2025.

What is the core business of LifeMD, Inc.?

LifeMD, Inc. is a telehealth provider offering a comprehensive platform that connects physicians, healthcare providers, and patients through secure, virtual consultations. It integrates various digital health services to streamline primary care and specialty treatments.

How does LifeMD ensure the security of patient information?

The platform is built to be HIPAA-compliant and uses AES encryption to secure all communications and data exchanges. This focus on security ensures that sensitive patient information remains confidential and protected throughout every interaction.

Which services are offered through LifeMD's telehealth platform?

LifeMD’s platform offers virtual consultations, digital prescriptions, remote lab testing, cloud pharmacy services, and even custom telehealth diagnostic equipment. These services make it possible to manage a wide range of conditions in a secure and efficient manner.

What differentiates LifeMD from other telehealth providers?

LifeMD stands out due to its integrated technology, including proprietary scheduling algorithms, a clinician-centric EMR system, and custom-fabricated diagnostic equipment. This combination promotes both operational efficiency and a high level of secure patient care.

How is LifeMD structured in terms of business segments?

The company operates primarily through its Telehealth division, which manages virtual care services, and a secondary segment known as WorkSimpli. This diversification allows LifeMD to offer comprehensive digital health solutions while addressing various market needs.

Who are the primary customers of LifeMD?

LifeMD primarily serves patients seeking convenient and secure access to healthcare, as well as healthcare providers requiring efficient digital tools to manage patient care. The platform is designed to bridge communication gaps between providers and patients across diverse demographics.

In what ways does LifeMD incorporate technology in its services?

LifeMD leverages state-of-the-art technologies such as encrypted communications, electronic medical records integration, digital prescription management, and remote lab testing to provide a holistic telemedicine solution. The use of proprietary algorithms further ensures efficient scheduling and case management.

How does LifeMD approach compliance and regulatory standards?

LifeMD prioritizes compliance by adhering to HIPAA regulations and ensuring that all patient interactions are securely encrypted. This commitment to meeting rigorous regulatory standards reinforces the trustworthiness and reliability of its telehealth services.